← Back
Data updated: Mar 29, 2026
PRINSTON INC
CardiovascularInfectious DiseaseNeurology
Generics
PRINSTON INC is a generic drug manufacturer focused on Cardiovascular, Infectious Disease, Neurology.
1979
Since
82
Drugs
-
Trials
1290
Approved (2yr)
Key Drugs
PAROXETINE
paroxetine hydrochloride
5-HT transporter 6 indications · 2014
VYDUO
nebivolol hydrochloride
3 indications · 2022
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
candesartan cilexetil
AT1 receptor 1 indications · 2012
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide
AT1 receptor 1 indications · 2016
VALSARTAN AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide
AT1 receptor · 2012
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
BUPROPION HYDROCHLORIDE 2026-02-25
Labeling
FINGOLIMOD HYDROCHLORIDE 2026-02-24
Labeling
PREGABALIN 2026-02-24
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
RIVAROXABAN 2026-02-20
DOXYCYCLINE HYCLATE 2026-02-19
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 62%
16 drugs
Infectious Disease 15%
4 drugs
Neurology 12%
3 drugs
Gastroenterology 8%
2 drugs
Oncology 4%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Bristol-Myers Squibb big-pharma
Oncology, Gastroenterology, Infectious Disease, Neurology
Pfizer big-pharma
Oncology, Infectious Disease, Gastroenterology
GE HEALTHCARE specialty
Infectious Disease, Neurology, Cardiovascular, Oncology
Merck big-pharma
Oncology, Infectious Disease, Cardiovascular
Novo Nordisk big-pharma
Oncology, Cardiovascular, Infectious Disease, Neurology
Active (41)
RIVAROXABAN LISDEXAMFETAMINE DIMESYLATE SAFINAMIDE MESYLATE VYDUO PEMETREXED DISODIUM FINGOLIMOD HYDROCHLORIDE LEVOMILNACIPRAN HYDROCHLORIDE TICAGRELOR ROFLUMILAST TADALAFIL PAROXETINE MESYLATE SILODOSIN OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL ARIPIPRAZOLE ESOMEPRAZOLE MAGNESIUM PAROXETINE TELMISARTAN CANDESARTAN CILEXETIL CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE VALSARTAN AND HYDROCHLOROTHIAZIDE PIOGLITAZONE HYDROCHLORIDE IRBESARTAN VORICONAZOLE LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE ROCURONIUM BROMIDE LEVETIRACETAM DIVALPROEX SODIUM VENLAFAXINE HYDROCHLORIDE BENAZEPRIL HYDROCHLORIDE LISINOPRIL LISINOPRIL AND HYDROCHLOROTHIAZIDE BISOPROLOL FUMARATE ENALAPRIL MALEATE ACYCLOVIR CLONAZEPAM AMPHETAMINE SULFATE DOXYCYCLINE METHYLPHENIDATE HYDROCHLORIDE DOXYCYCLINE HYCLATE HYDROCHLOROTHIAZIDE
Discontinued (40)
BUPROPION HYDROCHLORIDE PREGABALIN TELMISARTAN AND HYDROCHLOROTHIAZIDE GLYCOPYRROLATE ROPINIROLE HYDROCHLORIDE FENOFIBRATE LOSARTAN POTASSIUM IRBESARTAN AND HYDROCHLOROTHIAZIDE HYDROCODONE BITARTRATE AND ACETAMINOPHEN FUROSEMIDE QUETIAPINE FUMARATE POTASSIUM CHLORIDE HYDROXYZINE HYDROCHLORIDE CLOBETASOL PROPIONATE METFORMIN HYDROCHLORIDE RISPERIDONE QUINAPRIL HYDROCHLORIDE ESCITALOPRAM OXALATE PAROXETINE HYDROCHLORIDE FEBUXOSTAT DICYCLOMINE HYDROCHLORIDE CLOPIDOGREL BISULFATE PHENTERMINE HYDROCHLORIDE METOPROLOL SUCCINATE NEVIRAPINE PROMETHAZINE HYDROCHLORIDE VALSARTAN GLIMEPIRIDE METHOCARBAMOL DONEPEZIL HYDROCHLORIDE DULOXETINE HYDROCHLORIDE DOFETILIDE DIMETHYL FUMARATE CLONIDINE HYDROCHLORIDE ENTECAVIR CYCLOBENZAPRINE HYDROCHLORIDE BUSULFAN TEMAZEPAM CAPTOPRIL FOSINOPRIL SODIUM
Company Info
- First Approval
- 1979-10-29
- Latest
- 2026-02-17
- Applications
- 93